The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease

Since the use of the Model for End-Stage Liver Disease (MELD) score for establishing the prognosis of cirrhotic patients has been introduced, questions have been raised whether complications of liver cirrhosis would provide additional information. Myosteatosis, sarcopenia and hepatic encephalopathy (HE) are frequent in cirrhosis and may affect prognosis.Aim of the study was analyzing if these factors are independently related to survival and may improve the accuracy of MELD.

Source: Digestive and Liver Disease - October 6, 2019 Category: Gastroenterology Authors: Barbara Lattanzi, Silvia Nardelli, Alessandra Pigliacelli, Simone Di Cola, Alessio Farcomeni, Daria D ’Ambrosio, Stefania Gioia, Stefano Ginanni Corradini, Cristina Lucidi, Gianluca Mennini, Massimo Rossi, Manuela Merli, Oliviero Riggio Tags: Liver, Pancreas and Biliary Tract Source Type: research